logo
Thousands of cancer patients fear disruptions in care due to insurance contract dispute

Thousands of cancer patients fear disruptions in care due to insurance contract dispute

CNN01-07-2025
FacebookTweetLink Marla Puccetti spent all day Monday on the phone, urgently trying to reach someone at her health insurance company and the hospital that's treating her cancer.
'I've been on hold all day long, basically,' said Puccetti, 53, who co-owns a restaurant with her partner in Narrowsburg, New York.
Her health insurer, UnitedHealthcare, and her hospital, Memorial Sloan Kettering Cancer Center, have been locked in a contract dispute that wasn't resolved by the overnight deadline.
That means Puccetti and roughly 19,000 other cancer patients insured by UnitedHealthcare who are receiving treatment at Memorial Sloan Kettering are no longer in-network at the cancer center, it announced. They may face higher bills for their cancer treatment starting Tuesday.
Puccetti doesn't have out-of-network coverage on her current plan, so she would have to pay the full cost of her care, which she can't afford. But going anywhere but MSK for her treatment is unthinkable.
'It's terrifying. I don't want to go anywhere else,' she said. 'All of my doctors are there. All of my surgeons are there. I feel like they saved my life.'
The insurer and the cancer center, which has locations in New York City, New York state and New Jersey, had been in tense contract negotiations over rate increases that MSK said it needed to keep up with the cost of care.
UnitedHealthcare said MSK asked for a 30% increase in payments for its facilities and physicians, as well as a 36% increase for its cancer center. The insurer said the increases would drive up costs for consumers by $405 million over the next two years.
'We will remain at the negotiating table as long as it takes to renew our relationship with MSK. We ask MSK to join us there and to reach an agreement people and employers can afford,' UnitedHealthcare CEO Junior Harewood said in a statement Monday.
United said it delivered proposals to MSK on June 23 and June 30, but the hospital has so far declined the offers.
The insurer says it already reimburses MSK at rates significantly higher than other systems specializing in cancer care in the region.
Dr. Cardinale Smith, chief medical officer for MSK, disputes the idea that their cancer center is driving up the cost of care for patients. She says their cost of care is actually 4% to 16% lower than at comparable hospitals in the area.
'Our patients are getting better outcomes for total lower cost of care,' Smith said.
UnitedHealthcare is the nation's largest insurer, and she says hers isn't the only system that's being squeezed in contract negotiations with them.
'This is happening in other institutions as well, and it reflects what I think is a deeper tension in our health care system where there are financial priorities that are really being placed ahead of what's best for patients,' Smith said.
In 2021, Puccetti was diagnosed with breast and then cervical cancer just a few weeks apart. After a mastectomy and a hysterectomy, her breast cancer is in remission, but her cervical cancer has been tougher to snuff out. It has returned three times. She has tallied 60 rounds of radiation and 100 rounds of chemotherapy and has lost her hair three times.
Her tumor is in a bad spot, she says, attached to both her bladder and her bowel. Doctors said they could remove it surgically, but it would leave her dependent on bags hanging outside her body to collect urine and stool for the rest of her life, a situation she found untenable.
Now, she's on an immunotherapy drug that helps her body recognize and attack the cancer, with a goal of keeping it stable. She has been making the two-hour trip from her home in upstate New York to MSK about once a week for the past few months for tests to help doctors keep tabs on the tumor.
She got a letter just two weeks ago from UnitedHealthcare that said MSK might not be in her network starting July 1.
'It all came as a shock that this was actually happening,' she said.
On Monday, the two parties said they'd been unable to reach an agreement, leaving thousands of patients uncertain whether they'll be able to afford to continue their care at MSK.
In a statement to CNN, UnitedHealthcare said patients who are in active on ongoing treatment with an MSK provider when they go out of network will automatically receive continuity of care, meaning their care will still be covered at in-network rates for at least 90 days after the change takes effect. The insurer said patients don't need to apply for the extended benefits — they will be automatically granted.
Puccetti said she's unsure what she'll do. She's been researching other coverage options. Her UnitedHealthcare plan costs $3,200 a month, she says. It does provide some coverage, but she still owes 'thousands and thousands' in out-of-pocket costs.
Through it all, she's worked full-time at the restaurant, cooking, tending bar, keeping the books.
She applied for financial aid through Memorial Sloan Kettering but hasn't heard whether she qualifies.
Now, she says, she'll have to find an alternative.
'Everyone kept saying, 'well, don't panic, because they're going to come to a resolution.' So I tried not to panic, but how can you not?' she said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

11-year-old boy bravely fighting cancer throws first pitch at Fenway Park
11-year-old boy bravely fighting cancer throws first pitch at Fenway Park

CBS News

time8 minutes ago

  • CBS News

11-year-old boy bravely fighting cancer throws first pitch at Fenway Park

The Boston Red Sox celebrated an 11-year-old boy who is bravely fighting cancer. Max Acuto has gone from isolation in the ICU, to roaring applause filling Fenway Park. "There were so many times we were stuck in the house or the hospital because his counts were low, and we couldn't be surrounded by people. I'm just so happy to be here and have him have this experience," said Courtney Acuto, of her son. Max Acuto, throwing the first pitch Tuesday night, felt like a dream come true for the Princeton family living a nightmare. Their 9-year-old was diagnosed with T-cell acute lymphoblastic leukemia in 2023. Now 11, he's been so brave; a source of inspiration for the WPI baseball team, who have become his supporters and friends thanks to Team Impact. "I play a lot of baseball. I've been practicing a lot. It was really cool. Being on that field and how many people there were," Max said. Cheering Max on the mound is a moment of joy for this family after they have endured so much. But the true celebration comes this December when the sixth grader completes two years of grueling treatment. "Two out of three weeks he's getting chemotherapy. With the procedures he has to get, oral chemo at home, going in every Wednesday for treatment in clinic," said his dad Bryan Acuto. "I remember them telling us it was going to be two full years of chemo. I was like how do we even get there? He is so resilient; So easy going, always has a smile. Honestly he got us through our hardest days," Courtney added. After showing such quiet courage through the hard times, these good times... never seemed so good. "It's hard to imagine at the beginning of treatment we'd be here, and getting his strength back. Being able to watch that - the strength and perseverance he's shown has been really wonderful. The strength Max possesses I didn't know existed," Bryan said.

NFL Explains Why They Banned Smelling Salts From Games
NFL Explains Why They Banned Smelling Salts From Games

Yahoo

time29 minutes ago

  • Yahoo

NFL Explains Why They Banned Smelling Salts From Games

NFL Explains Why They Banned Smelling Salts From Games originally appeared on The Spun. The NFL has reportedly done away with a staple of its locker rooms and sidelines for decades. On Tuesday, star 49ers tight end George Kittle crashed the NFL Network's training camp set in Santa Clara to break the news that the league just put a ban on smelling salts and ammonia packets. Kittle, a nine-year NFL veteran, claims he used them every drive: "I honestly came here to air a grievance," the All-Pro began. "Our team got a memo today that [said] smelling salts and ammonia packets were made illegal in the NFL. I've been distraught all day. I considered retirement. We have to figure out a middle ground. Somebody help me out." After doing some digging, insider Mike Garafolo got a hold of the memo that was sent out to all 32 clubs about the new rule and apparently it has to do with a warning issued by the FDA last year. "In 2024, the FDA issued a warning to companies that produce commercially available ammonia inhalants (AIs), as well as to consumers about the purchase and use of AIs, regarding the lack of evidence supporting the safety or efficacy of AIs marketed for improving mental alertness or boosting energy," the memo read. "The FDA noted potential negative effects from AI use," it continued. "AIs also have the potential to mask certain neurologic signs and symptoms, including some potential signs of concussion. As a result, the NFL Head, Neck, and Spine Committee recommended prohibiting the use of AIs for any purpose during play in the NFL." The league noted that the new ban goes into effect immediately for the 2025 season which includes, "ammonia capsules, inhalers, ammonia in a cup or any form of 'smelling salts,'" and also applies to all team and league personnel "through the entirety of all NFL games [pregame and halftime]." As upset as some players are, it doesn't sound like the league is going to budge based on the wording. We'll see what types of alternatives they're able to come up with to give them the jolt they'll be missing this Explains Why They Banned Smelling Salts From Games first appeared on The Spun on Aug 5, 2025 This story was originally reported by The Spun on Aug 5, 2025, where it first appeared.

BeautyHealth (SKIN) To Report Earnings Tomorrow: Here Is What To Expect
BeautyHealth (SKIN) To Report Earnings Tomorrow: Here Is What To Expect

Yahoo

time36 minutes ago

  • Yahoo

BeautyHealth (SKIN) To Report Earnings Tomorrow: Here Is What To Expect

Skincare company BeautyHealth (NASDAQ:SKIN) will be announcing earnings results this Thursday after the bell. Here's what to look for. BeautyHealth beat analysts' revenue expectations by 8.9% last quarter, reporting revenues of $69.58 million, down 14.5% year on year. It was a very strong quarter for the company, with an impressive beat of analysts' gross margin estimates and a solid beat of analysts' EBITDA estimates. Is BeautyHealth a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting BeautyHealth's revenue to decline 17.5% year on year to $74.74 million, improving from the 22.9% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.02 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. BeautyHealth has missed Wall Street's revenue estimates twice over the last two years. Looking at BeautyHealth's peers in the personal care segment, some have already reported their Q2 results, giving us a hint as to what we can expect. USANA delivered year-on-year revenue growth of 10.8%, beating analysts' expectations by 4.7%, and Nature's Sunshine reported revenues up 3.8%, topping estimates by 2.2%. USANA traded up 12.4% following the results while Nature's Sunshine was also up 13.7%. Read our full analysis of USANA's results here and Nature's Sunshine's results here. Investors in the personal care segment have had fairly steady hands going into earnings, with share prices down 1.9% on average over the last month. BeautyHealth is down 25.9% during the same time and is heading into earnings with an average analyst price target of $1.66 (compared to the current share price of $1.63). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store